Skip to main content

Bright Minds Biosciences Inc. Common Stock (DRUG)

About The Company

DRUG Stock Market Logo

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company’s drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

IPO Year Sector Industry

Bright Minds Biosciences Inc. (DRUG) Latest News

Company Contact & Address (DRUG)

Corporate Headquarters Phone Website
New York,
United States
+1 647 865-8622 Official DRUG Website

DRUG Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector N/A P/E Ratio Not Available
Industry N/A Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ DRUG

Jobs & Employment at Bright Minds Biosciences Inc.

LinkedIn Company Page
Official Career & Employment Page See LinkedIn page for the careers & jobs info.

Related & Similar Stock Symbols

UGP Stock Market Price & News


Ultrapar Participacoes S.A. (New) American Depositary …

LFAC Stock Market Price & News


LF Capital Acquisition Corp. II Class A …

TSPQ Stock Market Price & News


TCW Special Purpose Acquisition Corp. Class A …